Sources of the figures for Yemen
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| UNICEF HIV/AIDS dataset | Modelled estimate | 1,375 | 5 | 2010–2025 | sdmx.data.unicef.org | 2026-10-20 |
| UNAIDS AIDSinfo | Modelled estimate | 740 | 19 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| WHO Global Health Observatory | Modelled estimate | 226 | 10 | 2000–2025 | ghoapi.azureedge.net | 2026-10-12 |
| WHO Global Tuberculosis Programme | Programme record | 155 | 16 | 2000–2025 | extranet.who.int | 2026-10-16 |
| World Bank Open Data | Modelled estimate | 51 | 2 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| IATI, through d-portal | Expenditure account | 38 | 3 | 2003–2026 | d-portal.org | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 33 | 3 | 2003–2021 | sdmx.oecd.org | 2026-10-12 |
| ForeignAssistance.gov | Expenditure account | 6 | 2 | 2009–2013 | foreignassistance.gov | 2026-10-29 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Actual expenditure on collaborative TB/HIV activities | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $14k (2024) |
| Budget required for collaborative TB/HIV activities | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $14k (2025) |
| Domestic funding received by the national TB programme | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $15k (2024) |
| Expected Global Fund funding for the national TB programme | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $2.1m (2025) |
| Expected USAID funding for the national TB programme | Financing | USD | 7 | 2019–2025 | WHO Global Tuberculosis Programme | $0 (2025) |
| Expected domestic funding for the national TB programme | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $15k (2025) |
| Expected funding for collaborative TB/HIV activities | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $4k (2025) |
| External HIV financing (all donors, ODA) | Financing | USD | 19 | 2003–2021 | OECD Creditor Reporting System | $528 (2021) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 14 | 2003–2023 | IATI, through d-portal | $0 (2023) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 12 | 2015–2026 | IATI, through d-portal | $51k (2026) |
| External HIV financing from the United States (ODA) | Financing | USD | 6 | 2009–2013 | ForeignAssistance.gov, OECD Creditor Reporting System | $50k (2013) |
| Funding received for collaborative TB/HIV activities | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $14k (2024) |
| Global Fund HIV disbursements to the country | Financing | USD | 23 | 2005–2017 | IATI, through d-portal, OECD Creditor Reporting System | $54k (2017) |
| Global Fund funding received by the national TB programme | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $1.9m (2024) |
| US HIV disbursements managed by other US agencies | Financing | USD | 3 | 2009–2013 | ForeignAssistance.gov | $50k (2013) |
| USAID funding received by the national TB programme | Financing | USD | 7 | 2017–2024 | WHO Global Tuberculosis Programme | $0 (2024) |
| % of ALL PLHIV who are virally suppressed | Treatment cascade | percent | 1 | 2025 | WHO Global Health Observatory | 30.0% (2025) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 67 | 2000–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 34.0% (2025) |
| % of PLHIV who have been diagnosed (first 95) | Treatment cascade | percent | 26 | 2010–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 43.0% (2025) |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 14 | 2005–2024 | UNAIDS AIDSinfo | 0.1% (2024) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 1 | 2013 | UNAIDS AIDSinfo | 7.3% (2013) |
| % of people on ART who are virally suppressed (third 95) | Treatment cascade | percent | 1 | 2025 | WHO Global Health Observatory | 89.0% (2025) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 5 | 2010–2014 | UNAIDS AIDSinfo | 2.0% (2014) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 6 | 2015–2024 | WHO Global Tuberculosis Programme | 0 (2024) |
| Number of people on ART (PEPFAR MER TX_CURR) | Treatment cascade | count | 67 | 2000–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 5,078 (2025) |
| PMTCT ART coverage among pregnant women with HIV | Treatment cascade | percent | 29 | 2010–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset | 14.0% (2025) |
| People newly enrolled on ART during the year | Treatment cascade | count | 1 | 2013 | WHO Global Tuberculosis Programme | 372 (2013) |
| Pregnant women tested for HIV in antenatal care | Treatment cascade | percent | 12 | 2010–2024 | UNAIDS AIDSinfo | 77.0% (2024) |
| Pregnant women with HIV who received ARVs for PMTCT | Treatment cascade | count | 30 | 2010–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 51 (2025) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 39 (2024) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 4,693 (2024) |
| AIDS-related deaths | Epidemic estimates | count | 681 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 590 (2025) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 31 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 2 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| HIV prevalence, ages 15-49 | Epidemic estimates | percent | 50 | 2000–2024 | UNAIDS AIDSinfo, World Bank Open Data | 0.1% (2024) |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 120 (2024) |
| New HIV infections | Epidemic estimates | count | 585 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 1,200 (2025) |
| People living with HIV | Epidemic estimates | count | 681 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 15,000 (2025) |
| Estimated pregnant women with HIV needing ARVs for PMTCT | Population denominators | count | 31 | 2010–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 500 (2025) |
| Estimated size of a key population | Population denominators | count | 2 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 41,773,878 (2025) |
| Share of HIV-exposed infants who acquire HIV | — | percent | 31 | 2010–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset | 37.8% (2025) |
Every row shown on the Yemen page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright